Zobrazeno 1 - 10
of 38
pro vyhledávání: '"M Victoria, Hernández"'
Autor:
Henar Suárez, Soraya López-Martín, Víctor Toribio, Moreno Zamai, M. Victoria Hernández-Riquer, Laura Genís, Alicia G. Arroyo, María Yáñez-Mó
Publikováno v:
Cells, Vol 9, Iss 2, p 348 (2020)
Membrane-bound proteases play a key role in biology by degrading matrix proteins or shedding adhesion receptors. MT1-MMP metalloproteinase is critical during cancer invasion, angiogenesis, and development. MT1-MMP activity is strictly regulated by in
Externí odkaz:
https://doaj.org/article/d627c74cda27402f9b2d9476c204dcb5
Autor:
Carlos Sanchez-Piedra, M. Victoria Hernández Miguel, Javier Manero, Rosa Roselló, Jesús Tomás Sánchez-Costa, Carlos Rodríguez-Lozano, Cristina Campos, Eduardo Cuende, Jesús Carlos Fernández-Lopez, Sagrario Bustabad, Raquel Martín Domenech, Eva Pérez-Pampín, Javier del Pino-Montes, Ana Milena Millan-Arciniegas, Federico Díaz-González, Juan Jesús Gómez-Reino
Publikováno v:
Reumatología Clínica (English Edition). 15:229-236
Autor:
Eduardo Cuende, M. Victoria Hernández Miguel, Raquel Martín Domenech, Rosa Roselló, Jesús T. Sánchez-Costa, Carlos Sánchez-Piedra, Javier del Pino-Montes, Jesús Carlos Fernández-Lopez, Carlos Rodríguez-Lozano, Ana Milena Millan-Arciniegas, Javier Manero, Eva Perez-Pampin, en representación del Grupo de trabajo Biobadaser Fase, Juan J. Gomez-Reino, Sagrario Bustabad, Federico Díaz-González, Cristina Campos
Publikováno v:
Reumatología Clínica. 15:229-236
Objective Describe the objectives, methods and results of the first year of the new version of the Spanish registry of adverse events involving biological therapies and synthetic drugs with an identifiable target in rheumatic diseases (BIOBADASER III
Autor:
Miguel Ángel Abad, Juan Carlos Obaya, Rafael Curbelo Rodríguez, Carmen Suárez, Juan Carlos Hermosa, Leticia Leon, Loreto Carmona, Carlos González, M. Victoria Hernández, Teresa Otón, Javier A. García, Julio Ramirez, Juan Carlos Torre-Alonso, Regina Dalmau, María Dolores Martín-Arranz, Juan Carlos Nieto-González, Santos Castañeda, Eduardo Collantes, Ana Urruticoechea-Arana
Publikováno v:
Reumatología Clínica. 14:346-359
Resumen Objetivos Identificar las comorbilidades prioritarias en la espondiloartritis axial (EspAx) y recomendar como hacer su seguimiento desde una perspectiva eminentemente practica. Metodos Se selecciono a un grupo multidisciplinar (10 reumatologo
Autor:
René Cordtz, Jacques Morel, Angela Zink, Xavier Mariette, Jacques-Eric Gottenberg, Florence Tubach, M. Victoria Hernández, Anne C. Regierer, Kimme L. Hyrich, Merete Lund Hetland, Florenzo Iannone, Karin Hellgren, William G Dixon, Lene Dreyer, Johan Askling, Louise K. Mercer, Jakub Zavada, Helena Canhão, Eva Baecklund, Anja Strangfeld, Joachim Listing
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2017, 76 (12), pp.2025--2030. ⟨10.1136/annrheumdis-2017-211623⟩
Mercer, L, Regierer, A, Mariette, X, Dixon, W, Baecklund, E, Hellgren, K, Dreyer, L, Lund Hetland, M, Cordtz, R, Hyrich, K, Strangfeld, A, Zink, A, Canhao, H, Hernández, M V, Tubach, F, Gottenberg, J-E, Morel, J, Zavada, J, Iannone, F, Askling, J & Listing, J 2017, ' The spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis : a European registries collaborative project ', Annals of the rheumatic diseases, vol. 76, no. 12, pp. 2025-2030 . https://doi.org/10.1136/annrheumdis-2017-211623
Mercer, L K, Regierer, A C, Mariette, X, Dixon, W G, Baecklund, E, Hellgren, K, Dreyer, L, Hetland, M L, Cordtz, R, Hyrich, K, Strangfeld, A, Zink, A, Canhao, H, Hernandez, M V, Tubach, F, Gottenberg, J-E, Morel, J, Zavada, J, Iannone, F, Askling, J & Listing, J 2017, ' Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis : a European registries collaborative project ', Annals of the Rheumatic Diseases, vol. 76, no. 12, pp. 2025-2030 . https://doi.org/10.1136/annrheumdis-2017-211623
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2017, 76 (12), pp.2025--2030. ⟨10.1136/annrheumdis-2017-211623⟩
Mercer, L, Regierer, A, Mariette, X, Dixon, W, Baecklund, E, Hellgren, K, Dreyer, L, Lund Hetland, M, Cordtz, R, Hyrich, K, Strangfeld, A, Zink, A, Canhao, H, Hernández, M V, Tubach, F, Gottenberg, J-E, Morel, J, Zavada, J, Iannone, F, Askling, J & Listing, J 2017, ' The spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis : a European registries collaborative project ', Annals of the rheumatic diseases, vol. 76, no. 12, pp. 2025-2030 . https://doi.org/10.1136/annrheumdis-2017-211623
Mercer, L K, Regierer, A C, Mariette, X, Dixon, W G, Baecklund, E, Hellgren, K, Dreyer, L, Hetland, M L, Cordtz, R, Hyrich, K, Strangfeld, A, Zink, A, Canhao, H, Hernandez, M V, Tubach, F, Gottenberg, J-E, Morel, J, Zavada, J, Iannone, F, Askling, J & Listing, J 2017, ' Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis : a European registries collaborative project ', Annals of the Rheumatic Diseases, vol. 76, no. 12, pp. 2025-2030 . https://doi.org/10.1136/annrheumdis-2017-211623
BackgroundLymphomas comprise a heterogeneous group of malignant diseases with highly variable prognosis. Rheumatoid arthritis (RA) is associated with a twofold increased risk of both Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL). It is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b2057a3755526e02a2c82f3a2c4f007
https://hal.archives-ouvertes.fr/hal-01755566
https://hal.archives-ouvertes.fr/hal-01755566
Autor:
Carlos, Sanchez-Piedra, M Victoria, Hernández Miguel, Javier, Manero, Rosa, Roselló, Jesús Tomás, Sánchez-Costa, Carlos, Rodríguez-Lozano, Cristina, Campos, Eduardo, Cuende, Jesús Carlos, Fernández-Lopez, Sagrario, Bustabad, Raquel, Martín Domenech, Eva, Pérez-Pampín, Javier, Del Pino-Montes, Ana Milena, Millan-Arciniegas, Federico, Díaz-González, Juan Jesús, Gómez-Reino
Publikováno v:
Reumatologia clinica. 15(4)
Describe the objectives, methods and results of the first year of the new version of the Spanish registry of adverse events involving biological therapies and synthetic drugs with an identifiable target in rheumatic diseases (BIOBADASER III).Multicen
Autor:
Enrique Calvo, Mara Martín-Alonso, Stephen J. Weiss, Fernando Martínez, Menno J. Oudhoff, Alicia G. Arroyo, Ángel Colmenar, M. Victoria Hernández-Riquer, Emilio Camafeita, Jesús Gómez-Escudero, Vanessa Moreno, Tamar Feinberg
Publikováno v:
Journal of Cell Science
Cadherin-based intercellular adhesions are essential players in epithelial homeostasis, but their dynamic regulation during tissue morphogenesis and remodeling remain largely undefined. Herein, we characterize an unexpected role for the membrane-anch
Autor:
Carlos González, Juan Carlos Obaya, Ana Urruticoechea-Arana, Juan Carlos Hermosa, Carmen Suárez, Teresa Otón, Leticia Leon, María Dolores Martín-Arranz, Juan Carlos Nieto-González, Javier A. García, Juan Carlos Torre-Alonso, Julio A. Ramirez, M. Victoria Hernández, Regina Dalmau, Rafael Curbelo Rodríguez, Santos Castañeda, Eduardo Collantes, Miguel Ángel Abad, Loreto Carmona
Publikováno v:
Reumatologia clinica. 14(6)
Objectives To identify priorities among comorbidities in axial spondyloarthritis (AxSpA) and recommend how to follow them from an eminently practical perspective. Methods A multidisciplinary group was selected (10 rheumatologists—6 of them experts
Autor:
Ronald F van Vollenhoven, Galina Lukina, Juan J. Gomez-Reino, Karel Pavelka, Matija Tomšič, Tore K Kvien, Elisabeth Lie, Ziga Rotar, Merete Lund Hetland, I. Ancuta, Almut Scherer, Maria José Santos, M. Victoria Hernández, Dan Nordström, Ellen Margrethe Hauge, Katerina Chatzidionysiou, Helena Canhão, Cem Gabay
Publikováno v:
Journal of rheumatology, 44(2), 162-169. Journal of Rheumatology
Chatzidionysiou, K, Lie, E, Lukina, G, Hetland, M L, Hauge, E-M, Pavelka, K, Gabay, C, Nordström, D, Canhao, H, Santos, M J, Tomsic, M, Rotar, Z, Hernández, M V, Gomez-Reino, J, Ancuta, I, Kvien, T K & van Vollenhoven, R 2017, ' Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort : Data from the CERERRA Collaboration ', Journal of Rheumatology, vol. 44, no. 2, pp. 162-169 . https://doi.org/10.3899/jrheum.160460
Chatzidionysiou, K, Lie, E, Lukina, G, Hetland, M L, Hauge, E M, Pavelka, K, Gabay, C, Scherer, A, Nordström, D, Canhao, H, Santos, M J, Tomsic, M, Rotar, Z, Hernández, M V, Gomez-Reino, J, Ancuta, I, Kvien, T K & Van Vollenhoven, R 2017, ' Rituximab retreatment in rheumatoid arthritis in a real-life cohort : Data from the CERERRA collaboration ', Journal of Rheumatology, vol. 44, no. 2, pp. 162-169 . https://doi.org/10.3899/jrheum.160460
Journal of Rheumatology, 44(2), 162-169. Journal of Rheumatology
Journal of Rheumatology, Vol. 44, No 2 (2017) pp. 162-169
Chatzidionysiou, K, Lie, E, Lukina, G, Hetland, M L, Hauge, E-M, Pavelka, K, Gabay, C, Nordström, D, Canhao, H, Santos, M J, Tomsic, M, Rotar, Z, Hernández, M V, Gomez-Reino, J, Ancuta, I, Kvien, T K & van Vollenhoven, R 2017, ' Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort : Data from the CERERRA Collaboration ', Journal of Rheumatology, vol. 44, no. 2, pp. 162-169 . https://doi.org/10.3899/jrheum.160460
Chatzidionysiou, K, Lie, E, Lukina, G, Hetland, M L, Hauge, E M, Pavelka, K, Gabay, C, Scherer, A, Nordström, D, Canhao, H, Santos, M J, Tomsic, M, Rotar, Z, Hernández, M V, Gomez-Reino, J, Ancuta, I, Kvien, T K & Van Vollenhoven, R 2017, ' Rituximab retreatment in rheumatoid arthritis in a real-life cohort : Data from the CERERRA collaboration ', Journal of Rheumatology, vol. 44, no. 2, pp. 162-169 . https://doi.org/10.3899/jrheum.160460
Journal of Rheumatology, 44(2), 162-169. Journal of Rheumatology
Journal of Rheumatology, Vol. 44, No 2 (2017) pp. 162-169
Objective.Several aspects of rituximab (RTX) retreatment in rheumatoid arthritis (RA) need to be further elucidated. The aim of this study was to describe the effect of repeated courses of RTX on disease activity and to compare 2 retreatment strategi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36e8ff7488a0c14ba90dff3aa059d208
https://pure.amc.nl/en/publications/rituximab-retreatment-in-rheumatoid-arthritis-in-a-reallife-cohort-data-from-the-cererra-collaboration(a154340d-6859-4935-b27e-9c90462b367f).html
https://pure.amc.nl/en/publications/rituximab-retreatment-in-rheumatoid-arthritis-in-a-reallife-cohort-data-from-the-cererra-collaboration(a154340d-6859-4935-b27e-9c90462b367f).html
Autor:
Javier Rueda-Gotor, Alejandro Olivé, Inmaculada Ros Vilamajo, Ricardo Blanco, Jordi del Blanco, Vanesa Calvo-Río, José Llobet, Trinitario Pina, Mercedes Freire, M. Victoria Hernández, Sara Manrique Arija, Chamaida Plasencia-Rodríguez, Adela Gallego Flores, Santos Castañeda, Catalina Gómez Arango, Walter Alberto Sifuentes Giraldo, Carlos Marras, Miguel A. Caracuel, Miguel A. González-Gay, Francisco Ortiz-Sanjuán, M. Carmen González-Vela, María Luisa Velloso-Feijoó, C. Mata, Javier Narváez, Ana Urruticoechea, Concepción Moll-Tuduri, Esteban Rubio Romero, Javier Loricera, Rosa Roselló
Publikováno v:
Arthritis & Rheumatology. 66:1659-1665
Objective Adult-onset Still's disease (AOSD) is frequently refractory to standard therapy. Tocilizumab (TCZ) has demonstrated efficacy in single cases and in small series of patients with AOSD. The aim of this multicenter study was to assess the effi